IMBARVA Trademark

Trademark Overview


On Wednesday, July 6, 2016, a trademark application was filed for IMBARVA with the United States Patent and Trademark Office. The USPTO has given the IMBARVA trademark a serial number of 79189838. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, June 30, 2023. This trademark is owned by Novartis AG. The IMBARVA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preven...
imbarva

General Information


Serial Number79189838
Word MarkIMBARVA
Filing DateWednesday, July 6, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, June 30, 2023
Registration Number5098030
Registration DateTuesday, December 13, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2016

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 30, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Thursday, February 29, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, June 30, 2023CANCELLED SECTION 71
Friday, October 27, 2017NOTIFICATION PROCESSED BY IB
Friday, June 30, 2017NOTIFICATION PROCESSED BY IB
Wednesday, February 15, 2017FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, February 15, 2017FINAL DISPOSITION PROCESSED
Thursday, January 12, 2017GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, December 13, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, September 27, 2016PUBLISHED FOR OPPOSITION
Wednesday, September 7, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 7, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 7, 2016NOTICE OF PUBLICATION
Monday, August 15, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 12, 2016APPLICATION FILING RECEIPT MAILED
Tuesday, August 9, 2016ASSIGNED TO EXAMINER
Monday, August 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 4, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 4, 2016SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB